RE — CBD Life Sciences Inc. (OTC: CBDL) today announced that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC Bioscience), has entered into negotiations to acquire a parcel of land in Mohave County, Arizona with the intent of commencing a commercial hemp growing operation. This strategic purchase will allow LBC Bioscience to grow its own hemp keeping complete control of key ingredients used in its products while providing additional revenue through the sale of hemp to third parties. The initial contract is for the purchase of 10 acres with the opportunity to acquire a total of 1,600. The seller also is offering turnkey hemp growing services along with site security management.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including: hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for your pets. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.
Contact Information
Investor Relations
Ten Associates LLC
11529 N. 120th St.
Scottsdale, Arizona
85259 USA
Telephone: 480-326-8577
Contact: Thomas E. Nelson
Email: tenassociates33@gmail.com
News 
Market Data 
Discover .jpeg)
